SCHEMBL18376245

SCHEMBL18376245

CN1CCN(c2cccc(Nc3ncc4cccc(-c5ccc(OCc6ccccc6)cc5)c4n3)c2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.53
▸ JAK3 P52333 4/20 0.53
▸ JAK1 P23458 2/20 0.53
▸ BRD4 O60885 3/20 0.52
▸ ALK Q9UM73 1/20 0.49
▸ TTK P33981 2/20 0.48
▸ NTRK1 P04629 1/20 0.48
▸ NTRK3 Q16288 1/20 0.48
▸ NTRK2 Q16620 1/20 0.48
▸ FGFR1 P11362 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ CDK4 P11802 2/20 0.46
▸ CCND1 P24385 2/20 0.46
▸ CCND2 P30279 2/20 0.46
▸ CCND3 P30281 2/20 0.46
▸ PTK2 Q05397 3/20 0.46
▸ MAP4K1 Q92918 2/20 0.46
▸ ABCB1 P08183 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ EGFR P00533 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29372248 1.00 JAK2 (0.53) JAK2JAK3JAK1BRD4ALK
SCHEMBL18376725 0.90 JAK2 (0.55) JAK2JAK3JAK1BRD4TTK
SCHEMBL29371281 0.90 JAK2 (0.55) JAK2JAK3JAK1BRD4TTK
SCHEMBL18377038 0.88 JAK2 (0.48) JAK2JAK3JAK1BRD4ALK
SCHEMBL18376743 0.88 JAK2 (0.48) JAK2JAK3JAK1BRD4TTK
SCHEMBL18376246 0.88 JAK2 (0.56) JAK2JAK3JAK1BRD4TTK
SCHEMBL29371334 0.88 JAK2 (0.56) JAK2JAK3JAK1BRD4TTK
SCHEMBL18376742 0.87 JAK2 (0.53) JAK2JAK3JAK1BRD4TTK
SCHEMBL29368360 0.87 JAK2 (0.53) JAK2JAK3JAK1BRD4TTK
SCHEMBL18377039 0.86 JAK2 (0.52) JAK2JAK3JAK1BRD4TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN disclosed
Send feedback